MRNA
$207.97+4.59%
as of close, Oct 27, 2026
☾ AH $207.97 +4.59%
MRNA — Moderna Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEEEEEEEEEEEEEEEEEEEE
50.0100.0150.0200.0250.0300.0350.0400.0450.00200.0M$207.97—20182020202220242026
2026-10-27
Price$207.97
MA20$137.34
MA50$85.78
Vol34.7M
Key stats#
Price data
- Price
- $207.97
- YTD price return
- +605.22%
- YTD total return
- +605.22%
- Next earnings
- Nov 6, 2026 · Before open
- Market cap
- 83B
- Enterprise value
- 82.6B
- Shares outstanding
- 399.2M
- 52W low
- $22.28
- 52W high
- $254.48
- From 52W high
- -18.28%
- From 52W low
- +833.44%
- 52W range
- 80%
- Beta
- 0.88
Volume
- Rel volume
- 0.92×
- 30D volume
- 19.1M
- 30D $ vol
- 3.8B
Insider trading
- Insider net 1W
- none
- Insider net 1M
- −$17.0M
- Insider net 3M
- −$62.6M
- Insider net 1Y
- −$80.9M
Form 4 transactions by trade date, as filed; latest on file 2026-10-15.
Fundamentals
- Sales (ttm)
- 2.2B
- Sales/share
- $5.58
- EPS (ttm)
- -$8.00
- FCF (ttm)
- -1.2B
- FCF/share
- -$3.12
- Book value/share
- $16.93
- Net margin
- -141.43%
- ROE
- -46.61%
- ROA
- -28.75%
- Debt / equity
- 0.09×
- Current ratio
- 2.29
Growth (CAGR, ttm) · 10Y
- Sales
- -27.63%-40.64%-20.51%+37.49%
- Shares
- +2.61%+1.61%-0.22%n/a
Per-share growth (CAGR, ttm) · 10Y
- Sales/share
- -29.47%-41.58%-20.33%n/a
- Book value/share
- -29.91%-27.55%+0.39%n/a
- Price
- +681.18%+42.46%-9.41%n/a
- Total return
- +681.18%+42.46%-9.41%n/a
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- -26.0×
- Fwd P/E
- -44.2×
- P/S (ttm)
- 37.3×
- P/B (mrq)
- 12.3×
- EV/Sales (ttm)
- 37.1×
- FCF yield (ttm)
- -1.50%
- Buyback yield (realized, 1y)
- -2.61%
- Shareholder yield (realized, 1y)
- -2.61%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.00%
Vs own 10Y history
- P/S
- 71st
- P/B
- 85th
Bar = where today’s multiple sits in MRNA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-27#
1D
+4.59%
5D
-14.09%
1M
+4.57%
3M
+273.85%
YTD
+605.22%
1Y
+680.08%
5Y
-38.99%
Recent filings#
- Sep 308-K · Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
- Sep 18-K · Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
- Jul 31Earnings · Earnings release — EPS −$1.97 vs −$1.97 est. (+0.0%); revenue $145.0M (+2% y/y) 5.4%
- Jul 88-K · Moderna Appoints Michael McDonnell to Board of Directors
Financial statements
Open full MRNA financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +8.32% | +0.22% |
| JNJ | Johnson & Johnson | -0.92% | +0.91% |
| ABBV | AbbVie Inc. | +8.34% | -0.12% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +8.98% | -0.08% |
| MRK | Merck & Co. Inc. | -4.68% | +0.86% |
| NVS | Novartis AG | +7.84% | +1.98% |
| TMO | Thermo Fisher Scientific Inc. | +2.67% | +1.19% |
| AMGN | Amgen Inc. | +8.04% | +0.75% |
